Cargando…

Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]

Detalles Bibliográficos
Autores principales: Chen, Chi-Wei, Wu, Ming-Hsi, Chen, Yi-Fan, Yen, Tsai-Yi, Lin, Yi-Wen, Chao, Shu-Hsin, Tala, Satishkumar, Tsai, Tung-Hu, Su, Tsann-Long, Lee, Te-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156521/
https://www.ncbi.nlm.nih.gov/pubmed/27978996
http://dx.doi.org/10.1016/j.neo.2016.10.005
_version_ 1782481278421958656
author Chen, Chi-Wei
Wu, Ming-Hsi
Chen, Yi-Fan
Yen, Tsai-Yi
Lin, Yi-Wen
Chao, Shu-Hsin
Tala, Satishkumar
Tsai, Tung-Hu
Su, Tsann-Long
Lee, Te-Chang
author_facet Chen, Chi-Wei
Wu, Ming-Hsi
Chen, Yi-Fan
Yen, Tsai-Yi
Lin, Yi-Wen
Chao, Shu-Hsin
Tala, Satishkumar
Tsai, Tung-Hu
Su, Tsann-Long
Lee, Te-Chang
author_sort Chen, Chi-Wei
collection PubMed
description
format Online
Article
Text
id pubmed-5156521
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-51565212016-12-21 Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212] Chen, Chi-Wei Wu, Ming-Hsi Chen, Yi-Fan Yen, Tsai-Yi Lin, Yi-Wen Chao, Shu-Hsin Tala, Satishkumar Tsai, Tung-Hu Su, Tsann-Long Lee, Te-Chang Neoplasia Corrigendum Neoplasia Press 2016-12-12 /pmc/articles/PMC5156521/ /pubmed/27978996 http://dx.doi.org/10.1016/j.neo.2016.10.005 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Chen, Chi-Wei
Wu, Ming-Hsi
Chen, Yi-Fan
Yen, Tsai-Yi
Lin, Yi-Wen
Chao, Shu-Hsin
Tala, Satishkumar
Tsai, Tung-Hu
Su, Tsann-Long
Lee, Te-Chang
Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title_full Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title_fullStr Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title_full_unstemmed Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title_short Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
title_sort corrigendum to “a potent derivative of indolizino[6,7-b]indole for treatment of human non–small cell lung cancer cells” [neoplasia 18 (2016) 199-212]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156521/
https://www.ncbi.nlm.nih.gov/pubmed/27978996
http://dx.doi.org/10.1016/j.neo.2016.10.005
work_keys_str_mv AT chenchiwei corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT wuminghsi corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT chenyifan corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT yentsaiyi corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT linyiwen corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT chaoshuhsin corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT talasatishkumar corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT tsaitunghu corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT sutsannlong corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212
AT leetechang corrigendumtoapotentderivativeofindolizino67bindolefortreatmentofhumannonsmallcelllungcancercellsneoplasia182016199212